Resveratrol Potentiates Effect of Simvastatin on Inhibition of Mevalonate Pathway in Human Endometrial Stromal Cells | Zendy

Jesus A. Villanueva | Zendy; Anna Sokalska | Zendy; Amanda B. Cress | Zendy; Israel Ortega | Zendy; Kaylon L. BrunerTran | Zendy; Kevin G. Osteen | Zendy; Antoni J. Dulęba | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Resveratrol Potentiates Effect of Simvastatin on Inhibition of Mevalonate Pathway in Human Endometrial Stromal Cells

Author(s) -

Jesus A. Villanueva,

Anna Sokalska,

Amanda B. Cress,

Israel Ortega,

Kaylon L. BrunerTran,

Kevin G. Osteen,

Antoni J. Dulęba

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-3387

Subject(s) - simvastatin , resveratrol , hmg coa reductase , reductase , mevalonic acid , mevalonate pathway , endocrinology , geranylgeranyl pyrophosphate , biology , cholesterol , biochemistry , medicine , hydroxymethylglutaryl coa reductase , biosynthesis , chemistry , enzyme

Growth of endometriotic lesions in rodent model of endometriosis is inhibited by resveratrol, a natural polyphenol with antiproliferative and antiinflammatory properties, and simvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research